Other specified type of carcinoma in situ of left breast
ICD-10 D05.82 is a billable code used to indicate a diagnosis of other specified type of carcinoma in situ of left breast.
Carcinoma in situ (CIS) of the breast refers to a non-invasive form of breast cancer where abnormal cells are found in the lining of the breast ducts or lobules but have not spread to surrounding tissues. The designation 'other specified type' indicates that the carcinoma does not fit into the more common categories such as ductal or lobular carcinoma in situ. This condition is significant as it represents a potential precursor to invasive breast cancer, necessitating careful monitoring and management. Patients diagnosed with D05.82 may undergo various surveillance protocols, including regular mammograms and clinical breast exams, to detect any progression to invasive disease. The risk of progression from carcinoma in situ to invasive breast cancer varies, with studies suggesting that approximately 30% of patients with untreated ductal carcinoma in situ may develop invasive cancer within 10 years. Therefore, timely intervention and adherence to surveillance protocols are crucial for patient outcomes.
Detailed pathology reports, treatment plans, and follow-up notes are essential for accurate coding.
Diagnosis of carcinoma in situ during routine screening, follow-up after initial diagnosis, and treatment planning.
Oncologists must ensure that all documentation reflects the specific type of carcinoma in situ to avoid coding errors.
Radiology reports must clearly indicate findings related to carcinoma in situ and any imaging studies performed.
Mammography findings suggestive of carcinoma in situ, imaging follow-up for surveillance.
Radiologists should provide comprehensive reports that correlate imaging findings with clinical diagnoses.
Used when a patient undergoes a lumpectomy for carcinoma in situ.
Operative reports must detail the procedure and findings.
Surgeons should ensure that the diagnosis of carcinoma in situ is clearly documented in operative notes.
Carcinoma in situ is a non-invasive form of cancer that can progress to invasive cancer if left untreated. Early detection and management are crucial for preventing progression.
